Press Releases

Agfa HealthCare announces that it will establish a new subsidiary in the Kingdom of Saudi Arabia. Called Agfa HealthCare Saudi Arabia Company Ltd., this legal entity will be formally launched at a press conference to be held on May 13 at the Ritz Carlton Hotel in Riyadh, Kingdom of Saudi Arabia.

Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today that they have released version 7.1.3 of the Visage® 7 Enterprise Imaging Platform.

According to a new survey by ETIAM, hospitals see a significant need for an organized system to manage the sizable flow of medical images many receive from beyond the enterprise.  Hospitals also expressed concern about the security of the cloud, which increasingly plays a role in cross-enterprise access to this patient data.

Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery - this is the finding of a new study conducted by PANAXEA, The University of Twente, Netherlands.

Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL, Amsterdam, the Netherlands) has signed an agreement to join a research group to advance the development of ground-breaking image-guided treatment technology for cancer care.

Leading research institutions are making breakthroughs in advanced MR imaging with Toshiba America Medical Systems, Inc.’s Vantage Titan™ 3T MR system. Toshiba has partnered with Shands at the University of Florida and the Keck Medical Center of the University of Southern California (USC) for MR research in fMRI, as well as body and cardiac imaging.

More than 300 radiologic technologists from Michigan visited with lawmakers in Lansing on April 17 to ask them to support expanded professional standards for the state’s personnel who perform medical imaging and radiation therapy procedures.

At the International Society for Magnetic Resonance in Medicine’s (ISMRM) 21st Annual Meeting & Exhibition in Salt Lake City, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today demonstrated a range of clinical functionalities in Magnetic Resonance Imaging (MRI)*, raising the bar on clinical excellence through greater collaboration, integration and increased patient focus.

Agfa HealthCare announced that Hunt Regional Healthcare, Greenville, Texas, has upgraded its Agfa HealthCare PACS to IMPAX 6.5 and installed Agfa HealthCare's Cardiology PACS and XERO Viewer to deliver a consolidated view and centralized management of patient, image and information data.

KLAS study finds that the requirement to work through licensed service providers (LSPs) is causing incumbent PACS to be commonly perceived as inferior to newer entrants into the market. The report entitled UK PACS 2013: The View Is Changing looks at leading PACS suppliers and finds that incumbent PACS and newer PACS have closer performance scores than commonly perceived when not delivered through LSPs.

Beaumont Hospital, Grosse Pointe has opened a new lung nodule clinic to provide early diagnosis and treatment of abnormal pulmonary nodules. Pulmonary nodules are a round or oval-shaped growth in the lung, sometimes referred to as a coin lesion or “spot” on the lung.

Like a pair of dancers sheathed in blue, two chromosomes take the cell’s center stage in this scene from the elegant—and usually perfectly performed—process of mitosis.

At the 2013 American Brachytherapy Society (ABS) meeting April 18-20 in New Orleans, Nucletron, an Elekta company, (booth #300), will introduce its newly redesigned Flexitron® remote afterloading platform.

Innovative online medical education company, SonoSim, Inc. introduced the SonoSim® Personal Solution at the recent AIUM conference held in NYC in April 2013.

The University of Texas MD Anderson Cancer Center (Houston, Texas) has purchased two Elekta Versa HD™ linear accelerators.

HealthTrust Purchasing Group (HealthTrust), one of the largest health care supply contracting companies in the United States, has awarded IRadimed Corporation a contract for its MRidium™ MRI Infusion Pump Systems.

The Harvey L. Neiman Health Policy Institute, one of the nation’s leading health care socioeconomic research organizations, today announced the awarding of six research grants to support studies of the role of diagnostic imaging in today’s changing health care payment and delivery structures.

Planmed Oy, the Finnish manufacturer of the Planmed Verity® Extremity Scanner, signed an exclusive U.S. nationwide distribution agreement with Merry X-Ray Corporation, the largest independent distributor of CR, DR, PACS and radiographic equipment in the U.S.

(Knoxville, TN, UNITED STATES) April 11, 2013– ABT Molecular Imaging, Inc., in Knoxville, TN, has successfully achieved the installation and clinical use of its next-generation Biomarker Generator by the Sveta Marina University Hospital in Bulgaria. ABT’s next-generation product integrates a compact accelerator and micro-chemistry with integrated quality control, for single-dose biomarker production.

Agfa HealthCare announces that it has implemented a complete IMPAX Picture Archiving and Communication System/Radiology Information System (PACS/RIS) and Clinical Application solution at the new National Guard Health Affairs (NGHA) hospital in Al Madinah, the Kingdom of Saudi Arabia. The comprehensive solution also includes IMPAX Business Intelligence plus two DX-D 600 Direct Radiography (DR) units.

Eli Lilly and Company (NYSE: LLY) today announced it has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA, Inc. The tracers are intended to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks of Alzheimer's disease. Based on studies of samples obtained at autopsy, the amount and location of tau tangles in an Alzheimer's disease patient's brain is thought to correlate with the severity of the disease. There are currently no approved diagnostics to detect tau tangles in living patients, creating challenges for scientists working to understand the progression of the disease and how therapies may impact it.